Status and expression of the p16INK4 gene in human thyroid tumors and thyroid‐tumor cell lines

Abstract

The p16INK4 tumor-suppressor gene (also known as CDKN2, CDK41 and MTSI) encodes a negative regulator of the cell cycle. This gene, located in 9p21, is mutated or homozygously deleted in a high percentage of tumor cell lines and specific types of primary tumors. We have examined the status of the p16INK4 gene in 31 thyroid tumors and 7 thyroid cell lines. No DNA abnormalities were found in primary tumors. Conversely, p16INK4 gene structural alterations, deletions and point mutations were found in 4 thyroid cell lines. The expression of the 2 different p16INK4 mRNAs, the p16α and p16β transcripts, was determined by RNA-PCR experiments. All the primary thyroid tumors expressed the β transcript, while the p16α was barely detectable. The thyroid cell lines always expressed the p16β transcript, while the α transcript was absent or, whenever present, coded for a mutated form of the p16INK4 gene product. Taken together, our results suggest that loss of p16INK4 function is not directly involved in the process of thyroid-tumor development, but it probably gives cells in tissue culture a selective growth advantage. © 1996 Wiley-Liss, Inc.